SCHEMBL5376822

SCHEMBL5376822

O=C(OCc1ccccc1)N1CCCC[C@@H]1S

nearest known ligand 0.58

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.53
▸ NPC1 O15118 1/20 0.53
▸ RAB9A P51151 1/20 0.53
▸ FKBP1A P62942 2/20 0.53
▸ PREP P48147 3/20 0.53
▸ CTRB1 P17538 1/20 0.53
▸ TMEM97 Q5BJF2 3/20 0.52
▸ SIGMAR1 Q99720 3/20 0.52
▸ CYP2C19 P33261 1/20 0.51
▸ ACE2 Q9BYF1 2/20 0.51
▸ KDM4E B2RXH2 1/20 0.51
▸ LMNA P02545 1/20 0.51
▸ CTSB P07858 1/20 0.49
▸ CTSS P25774 1/20 0.49
▸ CTSK P43235 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5326054 0.84 SMN1; SMN2 (0.55) SMN1; SMN2NPC1RAB9AFKBP1APREP
SCHEMBL14646671 0.83 FKBP1A (0.56) SMN1; SMN2NPC1RAB9AFKBP1APREP
SCHEMBL8329198 0.83 PREP (0.56) SMN1; SMN2NPC1RAB9AFKBP1APREP
SCHEMBL82714 0.83 PREP (0.62) SMN1; SMN2NPC1RAB9AFKBP1APREP
SCHEMBL25756732 0.83 FKBP1A (0.56) SMN1; SMN2NPC1RAB9AFKBP1APREP
SCHEMBL630241 0.83 PREP (0.62) SMN1; SMN2NPC1RAB9AFKBP1APREP
SCHEMBL630208 0.83 PREP (0.62) SMN1; SMN2NPC1RAB9AFKBP1APREP
SCHEMBL4985728 0.83 SMN1; SMN2 (0.53) SMN1; SMN2NPC1RAB9AFKBP1APREP
SCHEMBL30581660 0.83 FKBP1A (0.53) SMN1; SMN2NPC1RAB9AFKBP1APREP
SCHEMBL30612198 0.83 FKBP1A (0.53) SMN1; SMN2NPC1RAB9AFKBP1APREP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1869052-A1 SUBSTITUTED HETEROCYCLES AND THEIR USE AS CHK1, PDK1 AND PAK INHIBITORS AstraZeneca AB (SE) 2007-12-26 — — EP disclosed
WO-2006106326-A1 SUBSTITUTED HETEROCYCLES AND THEIR USE AS CHK1, PDK1 AND PAK INHIBITORS ASTRAZENECA AB (SE) 2006-10-12 — — WO disclosed
Send feedback